恆指曾倒跌逾200點 龍湖及碧桂系跌逾6%-7% 阿里健康逆市續升6%
摩通11月全球製造業PMI收縮持續惡化至近兩年半低,加上美國11月製造業兩年半來首陷收縮兼遜預期。美股期貨全面跌0.2%-0.4%,其中道指期貨報34,361,續跌68點或0.2%。亞太股市今早普遍下跌,尤其是日經及韓股回吐1.8%及1.2%。
恆指過去三天累漲逾千四點曾高見19,237(受制9月14日下跌裂口頂部19,296)後,今早高開48點或近0.3%報18,785,反覆高見18,841無以為繼,曾倒跌205點低見18,530,現報18,633,倒跌102點或0.5%,總成交額674億元。
藍籌股普遍反覆受壓,地產股跑輸,尤其是碧桂園(02007.HK)及龍湖(00960.HK)跌逾6.5%-7%,報2.77元及21.5元;潤地(01109.HK)、中海外(00688.HK)、九倉置業(01997.HK)及恆地(00012.HK)反覆跌約2%-2.5%。碧服(06098.HK)吐近7%報18.24元。
內需股比亞迪(01211.HK)、吉利(00175.HK)、潤啤(00291.HK)及蒙牛(02319.HK)反覆吐2%-4%。出口股申洲(02313.HK)倒跌4.4%報71.3元。
金融股以港交所(00388.HK)及中國平安(02318.HK)沽壓較大,股價反覆吐近2%。
然而,創科(00669.HK)續升1%曾高見99.15元;聯通(00762.HK)及美團(03690.HK)曾倒升逾4%高見4.59元及171.5元,現報4.49元及166.6元,倒升1.8%及2.3%。阿里(09988.HK)高見85.75元,現報83.75元,續升1.1%。獲匯豐及大和升價兼維持正面評級的阿里健康(00241.HK)曾高見7.14元,為今年1月以來最高,現報7.01元,續升6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.